Correlation Between Sellas Life and Lipocine
Can any of the company-specific risk be diversified away by investing in both Sellas Life and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sellas Life Sciences and Lipocine, you can compare the effects of market volatilities on Sellas Life and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Lipocine.
Diversification Opportunities for Sellas Life and Lipocine
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sellas and Lipocine is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Sellas Life i.e., Sellas Life and Lipocine go up and down completely randomly.
Pair Corralation between Sellas Life and Lipocine
Considering the 90-day investment horizon Sellas Life Sciences is expected to generate 2.64 times more return on investment than Lipocine. However, Sellas Life is 2.64 times more volatile than Lipocine. It trades about 0.14 of its potential returns per unit of risk. Lipocine is currently generating about -0.17 per unit of risk. If you would invest 106.00 in Sellas Life Sciences on November 18, 2024 and sell it today you would earn a total of 26.00 from holding Sellas Life Sciences or generate 24.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sellas Life Sciences vs. Lipocine
Performance |
Timeline |
Sellas Life Sciences |
Lipocine |
Sellas Life and Lipocine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sellas Life and Lipocine
The main advantage of trading using opposite Sellas Life and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.Sellas Life vs. NLS Pharmaceutics AG | Sellas Life vs. Mereo BioPharma Group | Sellas Life vs. Day One Biopharmaceuticals | Sellas Life vs. Reviva Pharmaceuticals Holdings |
Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |